Agency
The three existing Agency reviews now cover Night Renew Rx, Dark Spot Rx and Eye Revive Rx at their current names, pack sizes and public prices. An ingredient menu still needs an individual prescription.
MODEL
Clinician-selected compounded prescriptions with recurring product offers.
The brand verdict
Agency's current product pages provide more concrete quantity information than the older reviews described. The names and public prices have changed enough that the previous company assessment needed a rewrite, not an extra link.
Across these three offers, the useful distinction is between a candidate ingredient list and the actual formula. Tretinoin is not universal across the Night Renew and Eye Revive prescriptions, and Dark Spot includes hydroquinone and non-hydroquinone possibilities.
This profile assesses those disclosures. It does not validate every possible compound, compare patient outcomes or evaluate other Agency products newly appearing in the catalogue.
- Publishes quantity and nominal supply duration for all three reviewed offers.
- Acknowledges that ingredients vary by prescription.
- Describes clinician-directed changes for the pigment offering.
The range
- R-152026-09-13
Night Renew Rx
FORMERLY FUTURE FORMULAThe former Future Formula page now lists Night Renew Rx. This review replaces the older pricing and formula assumptions with the current offer, including the distinction between possible ingredients and a prescribed combination.
CONDITIONAL$130 PER ORDER
- R-162026-09-13
Dark Spot Rx
FORMERLY DARK SPOT FORMULAThe updated product page describes hydroquinone and non-hydroquinone options, with a published pack size and a new price. Formula transitions should follow the clinician's plan, not an assumed subscription calendar.
CONDITIONAL$110 PER ORDER
- R-172026-09-13
Eye Revive Rx
FORMERLY EYE FORMULAA renamed offering with current price and mass, a possible tretinoin component and no universal formula. The decision should begin with the proposed ingredients and application boundaries, not the fact that a second product is available.
CONDITIONAL$110 PER ORDER
What repeats across the range
These findings are drawn from the reviewed offerings above. They describe the assessed range, rather than every product or service the company provides.
- 01
The public offer has changed
Night Renew, Dark Spot and Eye Revive have published masses and nominal 60-day supplies. Existing patient terms may differ. Confirm the actual next charge rather than importing old monthly pricing from a search result.
- 02
The assigned ingredients drive the questions
A retinoid, a hormone, a depigmenting agent and a corticosteroid do not create the same prescribing discussion. Request the selected ingredients and concentrations, then ask why each belongs in your plan.
- 03
Transitions need clinical dates
A recurring shipment does not establish the appropriate duration of a particular formula. Ask when the prescription is reviewed, how changes are communicated and what happens to a shipment already scheduled.
- 04
Comparative strength is not comparative benefit
A more concentrated offering has not necessarily demonstrated more improvement or better tolerance than another finished product. The review separates those marketing comparisons from clinical outcome evidence.
Disclosure scorecard
Not what is in the product — what the company publishes about it, and where. “Findable” means the concentration exists somewhere, such as a help-centre article, rather than on the page you buy from.
SCROLL THE TABLE SIDEWAYS
| PRODUCT | OFFICIAL SOURCE | PERSONAL OUTCOMES TESTED |
|---|---|---|
| Night Renew Rx | YES | NO |
| Dark Spot Rx | YES | NO |
| Eye Revive Rx | YES | NO |
Reviewed options
Night Renew Rx
Worth buying for a specific person with a specific problem. Read who.
Eye Revive Rx
Worth buying for a specific person with a specific problem. Read who.
Sources
- S-01Agency — Night Renew Rx, formerly Future Formula
Current name, $130 price, 24 g / 60-day supply, ingredient menu and formula-specific bases. Strength comparisons are not clinical outcome comparisons. Checked 13 September 2026.
- S-02Agency — Dark Spot Rx
Current $110 price, 18 g / 60-day supply, possible hydroquinone and non-hydroquinone formulas, and clinician-directed transitions. Checked 13 September 2026.
- S-03Agency — Eye Revive Rx
Current $110 price, 12 g / 60-day supply and candidate ingredients; not every prescription contains tretinoin. Checked 13 September 2026.
- S-04FDA — understanding compounded-drug risks
Compounded preparations do not undergo FDA premarket review for safety, effectiveness or quality; they can meet individual medical needs. Checked 13 September 2026.